Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.

Alexander E, Goldberg L, Das AF, Moran GJ, Sandrock C, Gasink LB, Spera P, Sweeney C, Paukner S, Wicha WW, Gelone SP, Schranz J.

JAMA. 2019 Sep 27. doi: 10.1001/jama.2019.15468. [Epub ahead of print]

PMID:
31560372
2.

Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia.

Bhavnani SM, Zhang L, Hammel JP, Rubino CM, Bader JC, Sader HS, Gelone SP, Wicha WW, Ambrose PG.

J Antimicrob Chemother. 2019 Apr 1;74(Supplement_3):iii35-iii41. doi: 10.1093/jac/dkz089.

3.

Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing.

Wicha WW, Prince WT, Lell C, Heilmayer W, Gelone SP.

J Antimicrob Chemother. 2019 Apr 1;74(Supplement_3):iii19-iii26. doi: 10.1093/jac/dkz087.

4.

Efficacy and Safety of IV-to-Oral Lefamulin, a Pleuromutilin Antibiotic, for Treatment of Community-Acquired Bacterial Pneumonia: The Phase 3 LEAP 1 Trial.

File TM Jr, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, Seltzer E, Paukner S, Wicha WW, Talbot GH, Gasink LB.

Clin Infect Dis. 2019 Feb 4. doi: 10.1093/cid/ciz090. [Epub ahead of print]

PMID:
30722059
5.

Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance Mechanisms.

Mendes RE, Paukner S, Doyle TB, Gelone SP, Flamm RK, Sader HS.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02158-18. doi: 10.1128/AAC.02158-18. Print 2019 Apr.

6.

Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016).

Paukner S, Gelone SP, Arends SJR, Flamm RK, Sader HS.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02161-18. doi: 10.1128/AAC.02161-18. Print 2019 Apr.

7.

Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, Gelone SP, Broom C, Davidson DM; Polymer Alternative for CDI Treatment (PACT) investigators.

Clin Infect Dis. 2014 Aug 1;59(3):345-54. doi: 10.1093/cid/ciu313. Epub 2014 May 5.

PMID:
24799326
8.

The newer fluoroquinolones.

O'Donnell JA, Gelone SP.

Infect Dis Clin North Am. 2004 Sep;18(3):691-716, x. Review.

PMID:
15308282
9.

Caspofungin acetate for treatment of invasive fungal infections.

Pacetti SA, Gelone SP.

Ann Pharmacother. 2003 Jan;37(1):90-8. Review.

PMID:
12503942
10.

Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study.

Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP.

Sex Transm Infect. 2001 Feb;77(1):53-7.

11.

Fluoroquinolones.

O'Donnell JA, Gelone SP.

Infect Dis Clin North Am. 2000 Jun;14(2):489-513, xi. Review.

PMID:
10829268
12.

Hydroxyurea in the treatment of human immunodeficiency virus infection.

Gelone SP, Kostman JR.

Am J Health Syst Pharm. 1999 Aug 1;56(15):1554-7. Review. No abstract available.

PMID:
10478997
13.

Difficult-to-treat trichomoniasis: results with paromomycin cream.

Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Gelone SP.

Clin Infect Dis. 1998 Apr;26(4):986-8.

PMID:
9564487
14.

More on usability of lorazepam admixtures for continuous infusion.

Boullata JI, Gelone SP.

Am J Health Syst Pharm. 1996 Nov 15;53(22):2754-5. No abstract available.

PMID:
8931823
15.

Precipitation of lorazepam infusion.

Boullata JI, Gelone SP, Mancano MA, Borenstein MR, Zitterman RE.

Ann Pharmacother. 1996 Sep;30(9):1037-8. No abstract available.

PMID:
8876873
16.

Paromomycin for nitroimidazole-resistant trichomonosis.

Nyirjesy P, Weitz MV, Gelone SP, Fekete T.

Lancet. 1995 Oct 21;346(8982):1110. No abstract available.

PMID:
7564825
17.

Availability of lorazepam after simulated administration from glass and polyvinyl chloride containers.

Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR.

Am J Health Syst Pharm. 1995 Oct 15;52(20):2213-6. No abstract available.

PMID:
8564593

Supplemental Content

Loading ...
Support Center